Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis.
Identifieur interne : 006B62 ( Main/Exploration ); précédent : 006B61; suivant : 006B63Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis.
Auteurs : Andrew J. Spillane [Australie] ; Robyn P M. Saw ; Monica Tucker ; Karen Byth ; John F. ThompsonSource :
- Annals of surgery [ 1528-1140 ] ; 2008.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Analyse de régression, Analyse de survie, Association thérapeutique, Canal inguinal, Femelle, Humains, Indice de gravité médicale, Intervalles de confiance, Lymphadénectomie (), Lymphadénectomie (effets indésirables), Lymphoedème (), Lymphoedème (épidémiologie), Lymphoedème (étiologie), Membre inférieur, Mâle, Mélanome (), Mélanome (anatomopathologie), Mélanome (mortalité), Mélanome (secondaire), Métastase lymphatique, Odds ratio, Probabilité, Pronostic, Stade de la tumeur, Sujet âgé, Tumeurs cutanées (), Tumeurs cutanées (anatomopathologie), Tumeurs cutanées (mortalité), Valeur prédictive des tests, Études rétrospectives, Évaluation des risques.
- MESH :
- anatomopathologie : Mélanome, Tumeurs cutanées.
- effets indésirables : Lymphadénectomie.
- mortalité : Mélanome, Tumeurs cutanées.
- secondaire : Mélanome.
- épidémiologie : Lymphoedème.
- étiologie : Lymphoedème.
- Adulte, Adulte d'âge moyen, Analyse de régression, Analyse de survie, Association thérapeutique, Canal inguinal, Femelle, Humains, Indice de gravité médicale, Intervalles de confiance, Lymphadénectomie, Lymphoedème, Membre inférieur, Mâle, Mélanome, Métastase lymphatique, Odds ratio, Probabilité, Pronostic, Stade de la tumeur, Sujet âgé, Tumeurs cutanées, Valeur prédictive des tests, Études rétrospectives, Évaluation des risques.
English descriptors
- KwdEn :
- Adult, Aged, Combined Modality Therapy, Confidence Intervals, Female, Humans, Inguinal Canal, Lower Extremity, Lymph Node Excision (adverse effects), Lymph Node Excision (methods), Lymphatic Metastasis, Lymphedema (classification), Lymphedema (epidemiology), Lymphedema (etiology), Male, Melanoma (mortality), Melanoma (pathology), Melanoma (secondary), Melanoma (therapy), Middle Aged, Neoplasm Staging, Odds Ratio, Predictive Value of Tests, Probability, Prognosis, Regression Analysis, Retrospective Studies, Risk Assessment, Severity of Illness Index, Skin Neoplasms (mortality), Skin Neoplasms (pathology), Skin Neoplasms (therapy), Survival Analysis.
- MESH :
- adverse effects : Lymph Node Excision.
- classification : Lymphedema.
- epidemiology : Lymphedema.
- etiology : Lymphedema.
- methods : Lymph Node Excision.
- mortality : Melanoma, Skin Neoplasms.
- pathology : Melanoma, Skin Neoplasms.
- secondary : Melanoma.
- therapy : Melanoma, Skin Neoplasms.
- Adult, Aged, Combined Modality Therapy, Confidence Intervals, Female, Humans, Inguinal Canal, Lower Extremity, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Staging, Odds Ratio, Predictive Value of Tests, Probability, Prognosis, Regression Analysis, Retrospective Studies, Risk Assessment, Severity of Illness Index, Survival Analysis.
Abstract
This study aims to objectively define the criteria for assessing the presence of lymphedema and to report the prevalence of lymphedema after inguinal and ilio-inguinal (inguinal and pelvic) lymph node dissection for metastatic melanoma.
DOI: 10.1097/SLA.0b013e31817ed7c3
PubMed: 18650640
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003187
- to stream PubMed, to step Curation: 003187
- to stream PubMed, to step Checkpoint: 003187
- to stream Ncbi, to step Merge: 002E54
- to stream Ncbi, to step Curation: 002E54
- to stream Ncbi, to step Checkpoint: 002E54
- to stream Main, to step Merge: 006C69
- to stream Main, to step Curation: 006B62
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis.</title><author><name sortKey="Spillane, Andrew J" sort="Spillane, Andrew J" uniqKey="Spillane A" first="Andrew J" last="Spillane">Andrew J. Spillane</name><affiliation wicri:level="3"><nlm:affiliation>Sydney Melanoma Unit at the Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, Australia. andrew.spillane@smu.org.au</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Sydney Melanoma Unit at the Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Saw, Robyn P M" sort="Saw, Robyn P M" uniqKey="Saw R" first="Robyn P M" last="Saw">Robyn P M. Saw</name></author><author><name sortKey="Tucker, Monica" sort="Tucker, Monica" uniqKey="Tucker M" first="Monica" last="Tucker">Monica Tucker</name></author><author><name sortKey="Byth, Karen" sort="Byth, Karen" uniqKey="Byth K" first="Karen" last="Byth">Karen Byth</name></author><author><name sortKey="Thompson, John F" sort="Thompson, John F" uniqKey="Thompson J" first="John F" last="Thompson">John F. Thompson</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2008">2008</date><idno type="RBID">pubmed:18650640</idno><idno type="pmid">18650640</idno><idno type="doi">10.1097/SLA.0b013e31817ed7c3</idno><idno type="wicri:Area/PubMed/Corpus">003187</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003187</idno><idno type="wicri:Area/PubMed/Curation">003187</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003187</idno><idno type="wicri:Area/PubMed/Checkpoint">003187</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003187</idno><idno type="wicri:Area/Ncbi/Merge">002E54</idno><idno type="wicri:Area/Ncbi/Curation">002E54</idno><idno type="wicri:Area/Ncbi/Checkpoint">002E54</idno><idno type="wicri:Area/Main/Merge">006C69</idno><idno type="wicri:Area/Main/Curation">006B62</idno><idno type="wicri:Area/Main/Exploration">006B62</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis.</title><author><name sortKey="Spillane, Andrew J" sort="Spillane, Andrew J" uniqKey="Spillane A" first="Andrew J" last="Spillane">Andrew J. Spillane</name><affiliation wicri:level="3"><nlm:affiliation>Sydney Melanoma Unit at the Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, Australia. andrew.spillane@smu.org.au</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Sydney Melanoma Unit at the Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Saw, Robyn P M" sort="Saw, Robyn P M" uniqKey="Saw R" first="Robyn P M" last="Saw">Robyn P M. Saw</name></author><author><name sortKey="Tucker, Monica" sort="Tucker, Monica" uniqKey="Tucker M" first="Monica" last="Tucker">Monica Tucker</name></author><author><name sortKey="Byth, Karen" sort="Byth, Karen" uniqKey="Byth K" first="Karen" last="Byth">Karen Byth</name></author><author><name sortKey="Thompson, John F" sort="Thompson, John F" uniqKey="Thompson J" first="John F" last="Thompson">John F. Thompson</name></author></analytic><series><title level="j">Annals of surgery</title><idno type="eISSN">1528-1140</idno><imprint><date when="2008" type="published">2008</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Combined Modality Therapy</term><term>Confidence Intervals</term><term>Female</term><term>Humans</term><term>Inguinal Canal</term><term>Lower Extremity</term><term>Lymph Node Excision (adverse effects)</term><term>Lymph Node Excision (methods)</term><term>Lymphatic Metastasis</term><term>Lymphedema (classification)</term><term>Lymphedema (epidemiology)</term><term>Lymphedema (etiology)</term><term>Male</term><term>Melanoma (mortality)</term><term>Melanoma (pathology)</term><term>Melanoma (secondary)</term><term>Melanoma (therapy)</term><term>Middle Aged</term><term>Neoplasm Staging</term><term>Odds Ratio</term><term>Predictive Value of Tests</term><term>Probability</term><term>Prognosis</term><term>Regression Analysis</term><term>Retrospective Studies</term><term>Risk Assessment</term><term>Severity of Illness Index</term><term>Skin Neoplasms (mortality)</term><term>Skin Neoplasms (pathology)</term><term>Skin Neoplasms (therapy)</term><term>Survival Analysis</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Analyse de régression</term><term>Analyse de survie</term><term>Association thérapeutique</term><term>Canal inguinal</term><term>Femelle</term><term>Humains</term><term>Indice de gravité médicale</term><term>Intervalles de confiance</term><term>Lymphadénectomie ()</term><term>Lymphadénectomie (effets indésirables)</term><term>Lymphoedème ()</term><term>Lymphoedème (épidémiologie)</term><term>Lymphoedème (étiologie)</term><term>Membre inférieur</term><term>Mâle</term><term>Mélanome ()</term><term>Mélanome (anatomopathologie)</term><term>Mélanome (mortalité)</term><term>Mélanome (secondaire)</term><term>Métastase lymphatique</term><term>Odds ratio</term><term>Probabilité</term><term>Pronostic</term><term>Stade de la tumeur</term><term>Sujet âgé</term><term>Tumeurs cutanées ()</term><term>Tumeurs cutanées (anatomopathologie)</term><term>Tumeurs cutanées (mortalité)</term><term>Valeur prédictive des tests</term><term>Études rétrospectives</term><term>Évaluation des risques</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Mélanome</term><term>Tumeurs cutanées</term></keywords><keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Lymphadénectomie</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Lymph Node Excision</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Melanoma</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Mélanome</term><term>Tumeurs cutanées</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Melanoma</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" qualifier="secondaire" xml:lang="fr"><term>Mélanome</term></keywords><keywords scheme="MESH" qualifier="secondary" xml:lang="en"><term>Melanoma</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Melanoma</term><term>Skin Neoplasms</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Combined Modality Therapy</term><term>Confidence Intervals</term><term>Female</term><term>Humans</term><term>Inguinal Canal</term><term>Lower Extremity</term><term>Lymphatic Metastasis</term><term>Male</term><term>Middle Aged</term><term>Neoplasm Staging</term><term>Odds Ratio</term><term>Predictive Value of Tests</term><term>Probability</term><term>Prognosis</term><term>Regression Analysis</term><term>Retrospective Studies</term><term>Risk Assessment</term><term>Severity of Illness Index</term><term>Survival Analysis</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Analyse de régression</term><term>Analyse de survie</term><term>Association thérapeutique</term><term>Canal inguinal</term><term>Femelle</term><term>Humains</term><term>Indice de gravité médicale</term><term>Intervalles de confiance</term><term>Lymphadénectomie</term><term>Lymphoedème</term><term>Membre inférieur</term><term>Mâle</term><term>Mélanome</term><term>Métastase lymphatique</term><term>Odds ratio</term><term>Probabilité</term><term>Pronostic</term><term>Stade de la tumeur</term><term>Sujet âgé</term><term>Tumeurs cutanées</term><term>Valeur prédictive des tests</term><term>Études rétrospectives</term><term>Évaluation des risques</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This study aims to objectively define the criteria for assessing the presence of lymphedema and to report the prevalence of lymphedema after inguinal and ilio-inguinal (inguinal and pelvic) lymph node dissection for metastatic melanoma.</div></front></TEI><affiliations><list><country><li>Australie</li></country><region><li>Nouvelle-Galles du Sud</li></region><settlement><li>Sydney</li></settlement></list><tree><noCountry><name sortKey="Byth, Karen" sort="Byth, Karen" uniqKey="Byth K" first="Karen" last="Byth">Karen Byth</name><name sortKey="Saw, Robyn P M" sort="Saw, Robyn P M" uniqKey="Saw R" first="Robyn P M" last="Saw">Robyn P M. Saw</name><name sortKey="Thompson, John F" sort="Thompson, John F" uniqKey="Thompson J" first="John F" last="Thompson">John F. Thompson</name><name sortKey="Tucker, Monica" sort="Tucker, Monica" uniqKey="Tucker M" first="Monica" last="Tucker">Monica Tucker</name></noCountry><country name="Australie"><region name="Nouvelle-Galles du Sud"><name sortKey="Spillane, Andrew J" sort="Spillane, Andrew J" uniqKey="Spillane A" first="Andrew J" last="Spillane">Andrew J. Spillane</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006B62 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006B62 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:18650640
|texte= Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:18650640" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |